| Particulars |
| Company Name |
Natco Pharma Ltd |
| Face Value |
2 |
| BSE Code |
524816 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
35.82 |
| B.V. Rs |
409.50 |
| Sales Rs in Cr. |
4,094.50 |
| NP Rs in Cr. |
1,850.40 |
| NP Var% |
41.00 |
| Div% |
300.00 |
| CPS Rs |
115.60 |
| EPS Rs |
103.30 |
| Traded Value(Rs in Lakhs) |
2,237.16 |
| 52 Week High |
1,638.00 |
| 52 Week Low |
660.00 |
| Price BSE |
1,017.00 |
| Price NSE |
1,018.00 |
| Market Capital(Rs in Cr.) |
18,220.85 |
| P/C Ratio |
8.80 |
| P/E Ratio |
9.80 |
| Price Vs.BV |
2.48 |
| Latest Quarter |
| Year End |
202503 |
| Sales Rs in Cr. |
1,157.40 |
| NP Rs in Cr. |
428.10 |
| NP Var % |
23.00 |
| Trailing Twelve Months |
| Year End |
202503 |
| Sales |
4,119.60 |
| OPM |
54.49 |
| NP |
1,838.50 |
| NP Var% |
41.39 |
| EPS |
103.31 |
| PE |
9.85 |
|